Applied StemCell
Biotechnology Research • 
Milpitas, California, United States • 51-100 Employees
Company overview
| Headquarters | 521 Cottonwood Drive, Suite 111, Milpitas, CA 95035, US |
| Phone number | +18664974180 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Gene Therapy, Contract Research, Genomics, Cell Therapy, Bioproduction, Cdmo, Genome Editing, Cell Banking, Cho Cells, Crispr/Cas9, Ipsc Differentiation, Ipsc Disease Modeling, Antibody Discovery, Bioservices, Cell Manufacturing, Aav Potency Assays, Humanized Mouse, Safe Harbor Locus, Ipsc Generation, Hek293, Gmp Ipsc, Ipsc-Car-Nk, Biological Drugs, Gmp Doc Control |
| Founded | 2008 |
| Employees | 51-100 |
| Socials |
Key Contacts at Applied StemCell
Ruby Tsai
President/Founder
Cassandra Myers
Sales Director
Kaytrina Anchelia
Director Of Business Development
Pia Abola
Director Of Marketing
Simon Shu-Yu Wu
Director Of Technical Operations & Project Management
James Lulo
Director Of Business Development
Hainan Chen
Director Of Genome Technology Core
Applied StemCell Email Formats
Applied StemCell uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@appliedstemcell.com), used 78.9% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@appliedstemcell.com | 78.9% |
{first initial}.{last name} | j.doe@appliedstemcell.com | 15.8% |
{first initial} | j@appliedstemcell.com | 5.3% |
About Applied StemCell
Advancing Gene and Cell Product Development Through iPSC and Genome Editing Technologies Applied StemCell strives to advance gene-editing and stem cell innovation for biomedical research and the biotechnology industry to assist in the development of breakthrough therapeutic approaches to cure intractable diseases. ASC is a trailblazing CRO/CDMO committed to building a complete iPSC-Gene Editing platform for the production of iPSC-derived products for gene and cell therapy research and development. With the integration of our unique iPSC approach and IP-based site-specific large cargo insertion technology, TARGATT™, we (1) develop immune-compatible master iPS cell lines and (2) deliver large DNA fragments to pluripotent cells that have proven differentiation capabilities. We stand at the forefront of the iPSC-based therapy revolution delivering research- and GMP-grade iPSC solutions along with various downstream assay services. Current Offerings: • iPSC Cell Line Models: iPSC generation, CRISPR & TARGATT™ genome editing, differentiation • Cell Gene Product CDMO: TARGATT™ iPSC Platform for allogeneic cell therapy products/GMP iPSC reprogramming, cell banking, gene editing, and differentiation • Bioproduction: TARGATT™ CHO cell system for antibody screening and bioproduction/TARGATT™ HEK293 cell system for library/antibody screening • Animal Models: Custom and off-the-shelf CRISPR & TARGATT™ mouse models For patent licensing, business development, and investment inquiries, please contact us at info@appliedstemcell.com.
Applied StemCell revenue & valuation
| Annual revenue | $56,400,000 |
| Revenue per employee | $1,045,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $180,500,000 |
| Total funding | $19,000,000 |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Applied StemCell has 25 employees across 4 departments.
Departments
Number of employees
Applied StemCell Tech Stack
Discover the technologies and tools that power Applied StemCell's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Video players
Miscellaneous
Security
JavaScript libraries
Analytics
Form builders
JavaScript libraries
Maps
WordPress themes
Page builders
Miscellaneous
United Kingdom
Egypt
Frequently asked questions
4.8
40,000 users
